Clinical Safety of Bariatric Arterial Embolization: Preliminary Results of the BEAT Obesity Trial.

ABSTRACT: Purpose To conduct a pilot prospective clinical trial to evaluate the feasibility, safety, and short-term efficacy of bariatric embolization, a recently developed endovascular procedure for the treatment of obesity, in patients with severe obesity. Materials and Methods This is an institutional review board- and U.S. Food and Drug Administration-approved prospective physician-initiated investigational device exemption study. This phase of the study ran from June 2, 2014, to August 4, 2015. Five severely obese patients (four women, one man) who were 31-49 years of age and who had a mean body mass index of 43.8 kg/m² ± 2.9 with no clinically important comorbidities were enrolled in this study. Transarterial embolization of the gastric fundus with fluoroscopic guidance was performe

SUBMITTER: Weiss CR 

PROVIDER: S-EPMC5410948 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature